Centene Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Acquisitions (Tables)

Acquisitions (Tables)

3 Months Ended

Mar. 31, 2020

Schedule of Allocation of the Fair Value of Assets Acquired and Liabilities Assumed

The Company's preliminary allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January 23, 2020 is as follows ($ in millions):



Assets acquired and liabilities assumed
Cash and cash equivalents	$	2,899
Premium and related receivables	3,414
Short-term investments	403
Other current assets	1,158
Long-term investments	2,699
Restricted deposits	319
Property, software and equipment	270
Intangible assets ^(a)	7,000
Other long-term assets	261
Total assets acquired	18,423

Medical claims liability	3,962
Accounts payable and accrued expenses	3,142
Return of premium payable	238
Unearned revenue	223
Long-term debt^(b)	2,055
Deferred tax liabilities ^(c)	1,537
Other long-term liabilities	281
Total liabilities assumed	11,438

Total identifiable net assets	6,985
Goodwill ^(d)	10,620
Total assets acquired and liabilities assumed	$	17,605

Schedule of Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired

The preliminary fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:



	Fair Value		Weighted Average Useful Life (in years)
Purchased contract rights	$	5,200
Trade names	800
Provider contracts	700
Developed technologies	300
Total intangible assets acquired	$	7,000	13

Supplement Pro Forma Information

The following table presents supplemental pro forma information for the three months ended March 31, 2019 ($ in millions, except per share data):



	Three Months Ended March 31, 2019
Total revenues	$	25,169
Net earnings attributable to common stockholders	$	552
Diluted earnings per share	$	0.93